Isaac Kinde

Medical Scientist | Technology Assessment, Exact | Co-founder, Thrive

[Exact Sciences @ExactSciences]

Cologuard Plus™, our next-generation Cologuard® test, is now FDA approved. With 95% sensitivity for colorectal cancer and 43% sensitivity for advanced precancers, it sets a new performance standard for noninvasive screening. Read the full press release: https://t.co/RSbl4XzMZb

[Exact Sciences @ExactSciences]

We’re thrilled to announce that Resolution Bioscience will be joining the Exact Sciences family. This acquisition will further our mission by adding complementary capabilities to our growing portfolio. https://t.co/2wnCCvzOqM

[Exact Sciences @ExactSciences]

March 1st marks the start of #ColorectalCancerAwarenessMonth. We look forward to celebrating our patients, sharing some of their stories, and working to raise awareness about colorectal cancer and its impact.

[Exact Sciences @ExactSciences]

In the fight against cancer, the challenges and accomplishments of the Black community are often overlooked. This #BlackHistoryMonth, read about five leaders, including our own @IsaacKinde, who are working to increase equity: https://t.co/mLI8cnoBI0 @katiecouric

[Kevin Conroy @KevinConroyCEO]

We are thrilled to expand Exact Sciences’ presence in San Diego. Our focus for this facility will be to develop next-generation cancer diagnostics to help patients and physicians make better treatment decisions.

[Exact Sciences @ExactSciences]

This #WorldCancerDay, we’re using this space to share more from these partners and ways to get involved. See more in our Twitter Moment: https://t.co/32ga3HZCC5

[PreventionGenetics @PrevGenetics]

We are excited to announce that we are now a part of the @ExactSciences team. We look forward to continuing our work to help make genetic and hereditary cancer testing available to more patients, together. #ChangingLivesTogether https://t.co/FxCYYmhrCN

[Exact Sciences @ExactSciences]

We’re thrilled to welcome Everett Cunningham to our leadership team as Chief Commercial Officer. Learn more about his impressive background here: https://t.co/dGsXP2xVtg

[Exact Sciences @ExactSciences]

Katie Couric sits down with CEO Kevin Conroy to discuss our mission to eradicate cancer and how our teams are working to make it possible to detect cancers earlier. https://t.co/2JKQIF7hsy @katiecouric

[Isaac Kinde @IsaacKinde]

@AdamZiegel Thanks Adam! Very much appreciate your help in building the awesome team we have today

[Isaac Kinde @IsaacKinde]

@BhanSeema @ExactSciences How kind of you! Love how you’re enabling our mission from the policy perspective. And grateful for you laughing at my jokes ;)

[Isaac Kinde @IsaacKinde]

@KevinConroyCEO @ExactSciences Thanks Kevin and Exact! I’m so humbled by your kind words. Looking forward to helping Exact achieve our mission

[Isaac Kinde @IsaacKinde]

Honored to be included in this group of healthcare industry leaders

[Business Insider @BusinessInsider]

Meet Insider's 30 leaders under 40 transforming healthcare https://t.co/MolXYpEhw3

[Society for Immunotherapy of Cancer @sitcancer]

Congratulations to Dr. Karlo Perica of @sloan_kettering, recipient of the 2021 SITC-Bristol Myers Squibb (@bmsnews) Postdoctoral Cancer Immunotherapy Translational Fellowship, a 2-year, $200K SITC Fellowship! https://t.co/AWIZ1b7xet

[Sexy Soulaan 💜💛 @jaesofamous]

This is the best explanation of the Covid Vaccine I’ve ever heard.

[Exact Sciences @ExactSciences]

Semi Trotto, General Manager of Exact Sciences’ Thrive business unit, will be joining @Pharma_Intell panel of biopharma and med tech leaders to discuss leadership in times of uncertainty. Register here to join the webinar: https://t.co/0ZZdt0aGW5

[Exact Sciences @ExactSciences]

70% of cancers do not currently have a screening test. Sue's story shows why we must deliver new solutions for early detection, and how multi-cancer tests hold promise to lead the way. Read here via @KatieCouric: https://t.co/tpOiRKMKEI

[Johns Hopkins University @JohnsHopkins]

Together with @BloombergDotOrg, we are launching the Vivien Thomas Scholars Initiative, a $150 million effort to increase diversity in #STEM PhD programs, in partnership with HBCUs and MSIs. https://t.co/WWQAEDuE5a

[Exact Sciences @ExactSciences]

Dr. Bert Vogelstein’s vision for the future of screening inspires our work every day to advance our multi-cancer earlier detection blood test. https://t.co/Ohnz8cpuym

[Thrive Earlier Detection @ThriveDetect]

This lung cancer awareness month, our co-founder and head of research & innovation @IsaacKinde emphasizes the importance of screening & the significant impact our blood test had in detecting lung cancer in our DETECT-A study. The future of #earlierdetection is within reach. #LCAM